GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Camlin Fine Sciences Ltd

Camlin Fine Sciences plans Rs 250 Cr Rights Issue after Q2 FY27 results

FUNDRAISE ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 03 Nov 2026, 03:44 PM IST  ·  BSE ID: 3f151052-f307-41bc-8ee9-a3a5307f24a2
View Original BSE Filing (PDF)
💡
In Simple Terms
The company reported its financial results and announced plans for a new share offering to raise funds.
🤖 AI Summary
  • Board approved Q2 FY27 results; consolidated revenue INR 2,244.44 million.
  • Consolidated net profit for Q2 FY27 stood at INR 22.88 million.
  • Company plans to raise up to INR 250 crores via rights issue.
  • An administrative warning letter from SEBI was also noted.
  • Rights issue terms like price and ratio are to be determined later.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Consolidated Revenue - Quarter Ended 30.09.2026
2,244.44 million
Consolidated Profit After Tax - Quarter Ended 30.09.2026
22.88 million
Consolidated Revenue - Half Year Ended 30.09.2026
4,140.86 million
Consolidated Profit After Tax - Half Year Ended 30.09.2026
41.14 million
Standalone Revenue - Quarter Ended 30.09.2026
2,222.31 million
Standalone Profit After Tax - Quarter Ended 30.09.2026
38.10 million
Standalone Revenue - Half Year Ended 30.09.2026
4,483.80 million
Standalone Profit After Tax - Half Year Ended 30.09.2026
30.72 million
Proposed Rights Issue Amount
250 crores
🏢 How This Affects the Company
📈
Business Impact
The announcement of a rights issue suggests a strategic move to fund growth initiatives or strengthen the balance sheet.
💰
Financial Impact
A rights issue will dilute existing shareholding but provide capital. The Q2 FY27 results indicate revenue growth with a marginal profit.
⚠️
Risk Impact
The SEBI warning letter indicates a compliance issue that requires management attention.
👥 What This Means For Shareholders
✅
Action Required
Shareholders will need to decide whether to participate in the upcoming rights issue based on its final terms.
👤
Who Is Affected
Eligible equity shareholders as of the determined record date will have the opportunity to subscribe to the rights issue.
🔍
Management Signal
The decision to launch a rights issue signals management's intent to raise capital for strategic purposes.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Detailed terms of the rights issue
Finalization of the record date for the rights issue
Publication of financial results in newspapers
MEDIUM RISK SEBI warning letter and reduced profits in Q2 FY27 present compliance and performance concerns.
💡 Investor Takeaway
Camlin Fine Sciences reported consolidated revenue of INR 2,244.44 million and profit of INR 22.88 million for Q2 FY27. The company is proposing a rights issue to raise up to INR 250 crores.
⚖️ Strengths & Concerns

✅ Positives

  • Consolidated revenue grew to INR 2,244.44 million for Q2 FY27.
  • Consolidated net profit for H1 FY27 was INR 41.14 million.

⚠️ Concerns

  • Consolidated net profit for Q2 FY27 declined to INR 22.88 million from INR 254.60 million in Q2 FY26.
  • Stand-alone net profit for Q2 FY27 was INR 38.10 million, down from INR 130.36 million in Q2 FY26.
📅 Company Track Record
Previously, Camlin Fine Sciences confirmed 100% utilization of INR 22,468.39 Lakhs from a prior Rights Issue by March 31, 2026.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What were Camlin Fine Sciences' consolidated results for Q2 FY27?
For the quarter ended September 30, 2026, consolidated revenue was INR 2,244.44 million and consolidated profit after tax was INR 22.88 million.
How much does Camlin Fine Sciences plan to raise through a rights issue?
The company plans to raise funds by way of issue of equity shares through a rights issue for an amount not exceeding INR 250 crores.
What was the standalone profit for Camlin Fine Sciences in Q2 FY27?
The standalone profit after tax for the quarter ended September 30, 2026, was INR 38.10 million.
Did Camlin Fine Sciences receive any regulatory warnings?
Yes, the company noted an administrative warning letter dated October 29, 2026, from SEBI for violation of SEBI Listing Regulations.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.